
Archiv der Pharmazie p. 29 - 34 (1997)
Update date:2022-08-03
Topics:
Heinisch, Gottfried
Huber, Elisabeth
Matuszczak, Barbara
Maurer, Astrid
Prillinger, Ulrike
Starting from 3,6-dichloro-N-(2-chloro-5-nitrophenyl)-pyridazine-4-carboxamine (7) a series of 6,11-dialkylated pyridazino-[3,4-b][1,5]benzodiazepin-5-ones with a 3-chloro-8-nitro, 8-amino, 8-acetylamino, or 8-chloro substitution pattern was prepared via N-alkyl-3-alkylamino-6-chloro-N-(2-chloro-5-nitrophenyl)-pyridazine-4- carboxamides. The new compounds were screened as non-nucleoside reverse transcriptase inhibitors. The influence of the substitution pattern in compounds 10-13 on inhibitory potency is discussed.
View MoreContact:+1-973-357-0577
Address:10 Taft Rd.
Contact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Contact:+86-0311-84455288-844
Address:Mayu Industrial Park, Jinzhou, Hebei, China.
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
Guangzhou Probig Fine Chemical Co., Ltd.
Contact:020-86297874
Address:No.2, 1/F, No.20, Hetai Road,Hebian Village, Baiyun District,Guangzhou,China
Doi:10.1016/S0968-0896(97)00019-9
(1997)Doi:10.1021/acsmedchemlett.0c00272
(2020)Doi:10.1021/ja9700515
(1997)Doi:10.1039/a700386b
(1997)Doi:10.1016/S0277-5387(96)00579-7
(1997)Doi:10.1021/jo9624051
(1997)